Cohen Stuart H, Shetab Razeq, Tang-Feldman Yajarayma J, Sarma Praveena, Silva Joseph, Prindiville Thomas P
Division of Infectious and Immunologic Diseases, Department of Internal Medicine, University of California, Davis Medical Center, Sacramento, CA 95817, USA.
Diagn Microbiol Infect Dis. 2006 Aug;55(4):251-4. doi: 10.1016/j.diagmicrobio.2006.01.026. Epub 2006 May 2.
Stool specimens from 152 hospitalized patients with diarrhea were analyzed for the presence of enterotoxigenic Bacteroides fragilis (ETBF) by a nested polymerase chain reaction (PCR) assay. ETBF gene sequences were directly detected in 14/152 (9.21%) stools of patients. The prevalence of ETBF in hospital-acquired diarrhea was statistically significant when compared to a prevalence of 2.3% in control subjects (P = 0.04). B. fragilis was cultured from 19.7% (30/152) patients with diarrhea; 4 of these isolates were enterotoxigenic. To determine whether colonization with B. fragilis is heterogeneous in nature, multiple colonies from 17 individual patients were analyzed for enterotoxin gene sequences and genotyped by arbitrarily primed PCR. Of these 17 patients, 13 harbored multiple strain types suggesting heterogeneity of colonization with both enterotoxigenic and non-enterotoxigenic strains. Identification of ETBF in the stools of 10 patients in the absence of a positive culture is likely due to the noted heterogeneity and suggests that detection of enterotoxin by PCR should be performed directly in the stool. These preliminary data indicate that ETBF may play a role in hospital-acquired diarrhea of unknown origin and suggest the need for further studies.
采用巢式聚合酶链反应(PCR)分析法,对152例住院腹泻患者的粪便标本进行分析,以检测是否存在产肠毒素脆弱拟杆菌(ETBF)。在14/152(9.21%)例患者的粪便中直接检测到ETBF基因序列。与对照组2.3%的患病率相比,医院获得性腹泻中ETBF的患病率具有统计学意义(P = 0.04)。从19.7%(30/152)的腹泻患者中培养出脆弱拟杆菌;其中4株分离株产肠毒素。为了确定脆弱拟杆菌的定植在本质上是否具有异质性,对17例患者的多个菌落进行了肠毒素基因序列分析,并通过任意引物PCR进行基因分型。在这17例患者中,13例携带多种菌株类型,表明产肠毒素和非产肠毒素菌株的定植具有异质性。在10例患者的粪便中未进行阳性培养却鉴定出ETBF,这可能是由于上述异质性所致,提示应直接在粪便中通过PCR检测肠毒素。这些初步数据表明,ETBF可能在不明原因的医院获得性腹泻中起作用,并提示需要进一步研究。